ADMA Biologics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade ADMA Biologics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ADMA

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. 

CEO
Adam S. Grossman
CEOAdam S. Grossman
Employees
647
Employees647
Headquarters
Ramsey, New Jersey
HeadquartersRamsey, New Jersey
Founded
2004
Founded2004
Employees
647
Employees647

ADMA Key Statistics

Market cap
3.71B
Market cap3.71B
Price-Earnings ratio
25.30
Price-Earnings ratio25.30
Dividend yield
Dividend yield
Average volume
3.31M
Average volume3.31M
High today
$15.63
High today$15.63
Low today
$14.56
Low today$14.56
Open price
$14.95
Open price$14.95
Volume
4.35M
Volume4.35M
52 Week high
$25.67
52 Week high$25.67
52 Week low
$13.50
52 Week low$13.50

Stock Snapshot

With a market cap of 3.71B, ADMA Biologics(ADMA) trades at $15.57. The stock has a price-to-earnings ratio of 25.30.

On 2026-02-27, ADMA Biologics(ADMA) stock moved within a range of $14.56 to $15.63. With shares now at $15.57, the stock is trading +6.9% above its intraday low and -0.4% below the session's peak.

Trading volume for ADMA Biologics(ADMA) stock has reached 4.35M, versus its average volume of 3.31M.

Over the past 52 weeks, ADMA Biologics(ADMA) stock has traded between a high of $25.67 and a low of $13.50.

Over the past 52 weeks, ADMA Biologics(ADMA) stock has traded between a high of $25.67 and a low of $13.50.

ADMA News

Simply Wall St 1d
ADMA Biologics CFO Shift Puts Spotlight On Margins And Valuation

ADMA Biologics (NasdaqGM:ADMA) announced the retirement of long-serving CFO Brad Tade and the appointment of Terry Kohler as CFO and Treasurer. The company rep...

ADMA Biologics CFO Shift Puts Spotlight On Margins And Valuation
Simply Wall St 2d
Will ADMA’s Q4 2025 Earnings and Profit Focus Quiet Skeptics of Its Business Model?

On February 25, 2026, ADMA Biologics reported its Q4 2025 results after the market close, following earlier guidance that had set expectations around earnings a...

Will ADMA’s Q4 2025 Earnings and Profit Focus Quiet Skeptics of Its Business Model?

People also own

Based on the portfolios of people who own ADMA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.